Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-19 Purchase | 2024-11-19 7:59 pm | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 5,000 | $7.727 | $38,635 | 65,429 (Direct) | View |
| 2023-10-12 Purchase | 2023-10-12 5:09 pm | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 5,000 | $8.37 | $41,850 | 19,429 (Direct) | View |
| 2023-08-23 Sale | 2023-08-25 9:28 pm | iTeos Therapeutics Inc. | ITOS | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH Davis Aaron I. See remarks | 350,000 | $16.26 | $5,692,673 | 1,804,058 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-08 Gift | 2024-08-09 8:00 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 885,600 | $0 | 590,400 (Direct) | View |
| 2024-08-01 Option Award | 2024-08-05 07:19 am | 2025-08-01 2034-08-01 | iTeos Therapeutics Inc. | ITOS | Feltquate David Chief Medical Officer | 350,000 | $0 | 350,000 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 8:00 pm | 2025-06-11 2034-06-11 | iTeos Therapeutics Inc. | ITOS | Ho Tony W Director | 24,200 | $0 | 24,200 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 8:00 pm | 2025-06-11 2034-06-11 | iTeos Therapeutics Inc. | ITOS | Van Hauwermeiren Timothy Director | 24,200 | $0 | 24,200 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 8:00 pm | 2025-06-11 2034-06-11 | iTeos Therapeutics Inc. | ITOS | Lee David K Director | 24,200 | $0 | 24,200 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 8:00 pm | 2025-06-11 2034-06-11 | iTeos Therapeutics Inc. | ITOS | Davis Aaron I. Director | 24,200 | $0 | 24,200 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 8:00 pm | 2025-06-11 2034-06-11 | iTeos Therapeutics Inc. | ITOS | Hallal David Director | 24,200 | $0 | 24,200 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 8:00 pm | 2025-06-11 2034-06-11 | iTeos Therapeutics Inc. | ITOS | DeSimone Jill Director | 24,200 | $0 | 24,200 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 8:00 pm | 2025-06-11 2034-06-11 | iTeos Therapeutics Inc. | ITOS | RHOADS ANN D Director | 24,200 | $0 | 24,200 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 8:00 pm | 2025-06-11 2034-06-11 | iTeos Therapeutics Inc. | ITOS | Iannone Robert Director | 24,200 | $0 | 24,200 (Direct) | View |
| 2024-05-10 Option Award | 2024-05-14 9:32 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH Davis Aaron I. See remarks | 1,142,857 | $17.5 | 2,946,915 (Direct) | View |
| 2024-05-12 Other | 2024-05-14 9:06 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Former 10% Owner | 900,000 | $0 | 16,745,829 (Indirect) | View |
| 2024-03-07 Option Award | 2024-03-08 8:01 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 163,200 | $0 | 163,200 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 8:00 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 7:58 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer | 153,600 | $0 | 153,600 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 7:57 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 590,400 | $0 | 590,400 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-07 8:01 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | DeSimone Jill Director | 44,766 | $0 | 44,766 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 8:22 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer | 31,000 | $0 | 31,000 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 8:22 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 44,000 | $0 | 137,898 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 8:21 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 41,000 | $0 | 60,429 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 8:20 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Detheux Michel Chief Executive Officer | 30,000 | $0 | 58,903 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 8:17 pm | N/A 2033-12-05 | iTeos Therapeutics Inc. | ITOS | Lee David K Director | 44,766 | $0 | 44,766 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 7:57 pm | 2024-06-13 2033-06-13 | iTeos Therapeutics Inc. | ITOS | Van Hauwermeiren Timothy Director | 22,383 | $0 | 22,383 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 7:56 pm | 2024-06-13 2033-06-13 | iTeos Therapeutics Inc. | ITOS | RHOADS ANN D Director | 22,383 | $0 | 22,383 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 7:55 pm | 2024-06-13 2033-06-13 | iTeos Therapeutics Inc. | ITOS | Iannone Robert Director | 22,383 | $0 | 22,383 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 7:55 pm | 2024-06-13 2033-06-13 | iTeos Therapeutics Inc. | ITOS | Ho Tony W Director | 22,383 | $0 | 22,383 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 7:54 pm | 2024-06-13 2033-06-13 | iTeos Therapeutics Inc. | ITOS | Hallal David Director | 22,383 | $0 | 22,383 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 7:53 pm | 2024-06-13 2033-06-13 | iTeos Therapeutics Inc. | ITOS | DiRocco Derek Director | 22,383 | $0 | 22,383 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 7:52 pm | 2024-06-13 2033-06-13 | iTeos Therapeutics Inc. | ITOS | Davis Aaron I. Director | 22,383 | $0 | 22,383 (Direct) | View |
| 2023-03-28 Exercise | 2023-03-29 8:00 pm | N/A 2029-12-04 | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 40,226 | $0 | 201,762 (Direct) | View |
| 2023-03-28 Exercise | 2023-03-29 8:00 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 40,226 | $2.95 | 201,762 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-10 7:54 pm | N/A 2033-03-09 | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer | 130,000 | $0 | 130,000 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-10 7:53 pm | N/A 2033-03-09 | iTeos Therapeutics Inc. | ITOS | Lager Joanne Jenkins Chief Medical Officer | 130,000 | $0 | 130,000 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-10 7:53 pm | N/A 2033-03-09 | iTeos Therapeutics Inc. | ITOS | Gall Matthew Chief Financial Officer | 130,000 | $0 | 130,000 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-10 7:52 pm | N/A 2033-03-09 | iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer | 130,000 | $0 | 130,000 (Direct) | View |